Investor information
Nucleus news, financial results, company reports, governance structures, details of our board of directors and the latest share price information
Offer for the company
We’re Nucleus
The adviser-built wrap platform, supporting financial advisers in creating brilliant client outcomes.
Nucleus is an award-winning online wrap platform, launched in 2006 in partnership with a group of financial adviser firms who set out to create a platform with a difference. We created a new model, putting the adviser and client at the heart of the process, focusing on a client-aligned approach rather than a product-led one, to develop a platform that was committed to transparency and banishing complexity.
The platform allows advisers to combine all of their clients’ assets into a single, manageable online account. This enables portfolios to be viewed at a glance, allowing easy valuations and variations to be made.
Today we work with over 800 adviser firms and continue to be driven by advisers. We provide an entirely independent wrap platform with access to a wide range of tax wrappers and an open architecture approach to investments. The platform is built on next-generation technology allowing it to scale and is backed by award-winning customer service.

Notice of Annual General Meeting
Nucleus Financial Group plc Annual General Meeting (“AGM”) will be held at 9am on Thursday 27 May 2021 at Nucleus HQ, Greenside, 12 Blenheim Place, Edinburgh, EH7 5JH.
As we are asking shareholders not to attend the AGM in person, shareholders are invited to ask questions in advance of the AGM by submitting them to IR@nucleusfinancial.com. Answers to questions will be posted here as soon as practicable.
Any updates to our AGM arrangements and a link to the AGM broadcast on the date of the AGM will also be posted here.
2020 H2 financial results
Assets under administration
Net revenue
Operating profit
Board of directors
The Board is responsible for leading and governing the Group and has overall authority for the management and conduct of the Group’s business, strategy and development. The Board is also responsible for ensuring the maintenance of a sound system of internal controls and risk management (including financial, operational and compliance controls) and for reviewing the overall effectiveness of systems in place as well as for the approval of any changes to the capital, corporate and/or management structure of the Group.
The Board comprises eight Directors, two Executive Directors (David Ferguson and Stuart Geard) and six Non-Executive Directors, reflecting a blend of different experiences and backgrounds. The Non-Executive Directors comprise a Non-Executive Chairman (Angus Samuels) and five further Non-Executive Directors (John Levin, Margaret Hassall, Tracy Dunley-Owen, Alfio Tagliabue and Jonathan Polin). Full biographies for each director are available by clicking on the images below.
The Board considers Angus Samuels, John Levin, Margaret Hassall and Tracy Dunley-Owen to be independent Non-Executive Directors, and as such, free of any relationship which could materially interfere with the exercise of their independent judgement.
Reports and presentations
Nucleus Financial Group plc 2020
Nucleus Financial Services Limited 2020
Executive team
Our executive leadership team is responsible for the day-to-day management of the business and implementing Nucleus’ strategy.
AUA as at 31 March 2021
Clients
Adviser firms
Corporate governance
The executive management team and the board of directors recognise the value and importance of maintaining the highest standards of corporate governance and aim to comply with the principles set out in the UK QCA Corporate Governance Code. The QCA code sets out a standard of minimum best practice for small and medium-sized quoted companies, particularly AIM listed companies.
The Board intends to meet regularly to review, formulate and approve, among other things, the Group’s strategy, system of internal controls, budgets and corporate actions. The Company has established an Audit Committee, Risk Committee, Nomination Committee and a Remuneration Committee with formally delegated duties and responsibilities and with written terms of reference. From time to time, separate committees may be set up by the Board to consider specific issues when the need arises.
Audit committee
The Audit Committee’s role is to assist the Board with the discharge of its responsibilities in relation to external and internal audits and controls, including in respect of the Group’s CASS arrangements and reviewing the Group’s annual financial statements.
Nomination committee
The Nomination Committee assists the Board in determining the composition and make-up of the Board. It is responsible for reviewing the Board’s structure and identifying potential candidates to be appointed as directors, and for making recommendations to the Board.
Remuneration committee
The Remuneration Committee recommends what policy the Board should adopt on executive and senior management remuneration. It will also make recommendations on proposals for the granting of share options and other equity incentive plans.
Risk committee
The Risk Committee advises the Board on the Group’s overall risk appetite and strategy, regularly reviewing and updating the risk assessment processes, including in relation to remuneration and compliance, and overseeing implementation of the strategy.
Company advisers
Nominated adviser
Shore Capital and Corporate Limited
Cassini House, 57 St James's Street, London, SW1A 1LD
Broker
Shore Capital Stockbrokers Limited
Cassini House, 57 St James's Street, London, SW1A 1LD
Registrars
Equiniti
Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA
Independent auditors
PricewaterhouseCoopers LLP
Atria One, 144 Morrison Street, Edinburgh EH3 8EX
Company secretarial adviser
Prism CoSec
42-50 Hersham Road, Walton-on-Thames, Surrey KT12 1RZ
Public relations
Camarco
107 Cheapside, London, EC2V 6D
Regulated news
Date | Title | |
---|---|---|
13/01/2021 16:04 | Director/PDMR Shareholding | ![]() |
06/01/2021 14:35 | Q4 2020 AUA update | ![]() |
Date | Title | |
---|---|---|
17/12/2018 16:25 | Director/PDMR Shareholding | ![]() |
19/11/2018 07:00 | New Platform Agreement | ![]() |
26/10/2018 08:00 | Q3 2018 Update | ![]() |
08/10/2018 09:38 | Director/PDMR Shareholding | ![]() |
25/09/2018 13:12 | Director/PDMR Shareholding (Replacement) | ![]() |
25/09/2018 12:23 | Director/PDMR Shareholding | ![]() |
21/09/2018 08:00 | Holding(s) in Company | ![]() |
11/09/2018 08:00 | Interim report | ![]() |
01/08/2018 08:00 | H1 2018 AUA Update and Notice of Interim Results | ![]() |
26/07/2018 12:05 | Director/PDMR Shareholding | ![]() |
26/07/2018 08:00 | First Day of Dealings on AIM | ![]() |
20/07/2018 16:15 | AIM - Sch 1 update - Nucleus Financial Group Plc | ![]() |
11/07/2018 10:50 | AIM - Schedule 1 - Nucleus Financial Group Plc | ![]() |
02/07/2018 08:00 | Intention to Float | ![]() |